（转载自中国知识产权报）On November 10th, the 6th China International Import Expo (CIIE) successfully concluded. According to data, the annual intended turnover of transactions reached a record high of 78.41 billion U.S. dollars. At the 6th CIIE, more than 400 new products, technologies and services were unveiled. As important support for these new products, technologies and services, intellectual property rights (IPRs) created new opportunities for the innovative development of global enterprises.

Strengthening protection, boosting development confidence

Boehringer Ingelheim, a family-owned pharmaceutical company in Germany, made its fifth CIIE presence with a strong lineup of eight human drugs and innovative products for animal health. "With full trust in the potential and resilience of the Chinese market, and great appreciation for China's ever-improving business environment, we are willing to take root in China and grow with the Chinese market," said Pavol Dobrocky, President and CEO of Boehringer Ingelheim Greater China. "High-standard IPR protection has boosted our confidence in innovating and operating in China."

At the new development stage, China has aligned itself with international high-standard IPR rules and comprehensively strengthened IPR protection, creating an open, fair, impartial and non-discriminatory environment for innovation-driven development.

On the one hand, China has continuously enhanced legal guarantee for IPR protection. The Civil Code has established major legal principles for IPR protection; laws and regulations such as the Patent Law and the Trademark Law have set up the highest-standard punitive damages system, the system of administrative adjudication on major patent infringement disputes and other systems. On the other hand, China has protected the IPRs of foreign-funded enterprises on a non-discriminatory and equal basis. This August, the State Council issued the Opinions on Further Optimizing the Foreign Investment Environment and Stepping up Efforts to Attract Foreign Investments, to intensify the administrative enforcement of IPR laws and promote fair competition.

Promoting application, enriching commercialization results

With an average annual R&D investment of more than 120 million yuan, "Zespri SunGold Kiwifruit" and "Zespri RubyRed Kiwifruit" show the sincerity of Zespri Group Limited (Zespri) to develop the Chinese market.

"Protecting the right to new varieties of plants is an important move of Zespri to balance inputs and outputs, and stimulate innovation," said Bruce Cameron, Chairman of the Board of Zespri. "In our in-depth contact with the Chinese market, we've seen China's determination and ability to protect IPRs, including the right to new varieties of plants, as well as China's robust measures for promoting the application of IPRs, which have inspired us and boosted our confidence in pursuing sustained development in China."

How to promote the high-yield commercialization and use of IPRs is also a concern of foreign-funded enterprises that pursue sustainable development in China.

The Special Action Plan for Patent Commercialization and Utilization (2023-2025) issued by the General Office of the State Council this October proposed that overseas patentee and foreign-funded enterprises should be encouraged to commercialize patents under the principle of marketization. The China National Intellectual Property Administration (CNIPA) will work with relevant departments to improve the mechanism of communication with foreign-funded enterprises, protect the IPRs of them in strict accordance with law, and offer them better IPR services. In the meantime, CNIPA will encourage various countries to rely on the IPR cooperation mechanism among China, the U.S., Europe, Japan and the Republic of Korea, the BRICS IPR cooperation mechanism, as well as relevant forums and exhibitions, to promote dialogues with the industry, as well as the trading and commericialization of patented technologies and products under the principle of marketization and legalization.

Deepening cooperation, integrating innovation elements

Siemens Healthineers brought more than 20 new products and solutions to the 6th CIIE. "We are pleased to see China's formal accession to the Hague Agreement Concerning the International Registration of Industrial Designs in 2022, which enables more convenient design protection for medical devices; the CNIPA-EPO Pilot for ISA (International Search Authority) Files has also greatly facilitated international patent applications (under the PCT) by Siemens Healthineers and other European enterprises in China," said Pu Zhengrong, Vice President of Siemens Healthineers Greater China Vice.

Westwell Holdings (Hong Kong China) Limited showcased Q-Tractor, an all-time driverless new energy commercial vehicle starring in The Wandering Earth II; and Q-Truck, a driverless new energy tractor. To accelerate its global operations, Westwell has made the most of the Madrid system of trademark registration to promote its brand globally.

In recent years, China has continuously deepened international IPR exchanges and cooperation. China has established IPR cooperative ties with more than 80 countries and regions and international organizations around the world, constantly expanded the Patent Prosecution Highway (PPH) cooperation network that now connects 32 countries. In addition, China has pushed for the improvement of international IPR rules and standards, continuously established and improved foreign-related work mechanisms under international treaties, and gained more international recognition in terms of examination standards and conclusions. These measures and outcomes have provided critical support for the "inviting in" and "venturing out" of innovation elements.(by Li Yangfang)

11月10日，第六届中国国际进口博览会（下称进博会）圆满闭幕。数据显示，此届进博会按年计意向成交创历届新高，金额达784.1亿美元。进博会上，超400项新产品、新技术、新服务集中亮相。记者感受到，知识产权是这些新产品、新技术、新服务的重要支撑，为全球企业创新发展带来新机遇。

加强保护，提振发展信心

德国家族制药企业勃林格殷格翰连续第五次参加进博会，此次带来了8款人用药品及动物保健领域重磅创新产品的首秀首展。勃林格殷格翰大中华区总裁兼首席执行官董博文表示：“勃林格殷格翰愿意扎根中国，与中国市场共同成长。这源于其对中国市场潜力和韧性的充分信任，以及对中国不断改善的营商环境的赞赏。其中，高标准知识产权保护极大提振了勃林格殷格翰在华创新、经营的信心。”

在新发展阶段，中国积极对接国际高标准知识产权规则，全面加强知识产权保护工作，为创新驱动发展营造了开放、公平、公正、非歧视的环境。

一方面，中国持续夯实知识产权保护的法治保障。民法典确立了知识产权保护的重大法律原则，专利法、商标法等法律法规建立起国际上最高标准的惩罚性赔偿制度，以及重大专利侵权纠纷行政裁决等制度。另一方面，中国坚持一视同仁、同等保护外资企业的知识产权。今年8月，国务院印发《关于进一步优化外商投资环境加大吸引外商投资力度的意见》，加大知识产权行政执法力度，促进公平竞争。

促进运用，丰富转化成果

年均研发投入超过1.2亿元培育出的“阳光金果奇异果”和“佳沛红心奇异果”是新西兰佳沛国际集团（下称佳沛）敲开中国市场大门的诚意之礼。

“植物新品种权的保护是佳沛用以平衡投入、激励创新的重要内容，在与中国市场的深入接触中，佳沛看到了中国保护包括植物新品种权在内的知识产权的决心与能力，以及中国促进知识产权运用的有力举措，这令我们备受鼓舞，更加坚定了在中国持续发展的信心。”佳沛董事局主席布鲁斯·卡梅隆表示。

如何促进知识产权的高效益转化运用，同样是外资企业在华可持续发展所关心的问题。

今年10月，国务院办公厅印发的《专利转化运用专项行动方案（2023—2025年）》提出，鼓励海外专利权人、外商投资企业等按照自愿平等的市场化原则，转化实施专利技术。中国国家知识产权局将与相关部门一起完善与外资企业的沟通交流机制，依法严格保护外资企业的知识产权，为其提供更好的知识产权服务；同时，推动各国在市场化、法治化原则基础上，依托中美欧日韩、金砖国家等知识产权合作机制及相关论坛、展会活动，促进产业界对话交流和专利技术产品的交易转化。

深化合作，融通创新要素

此届进博会上，西门子医疗带来20余款新品和解决方案。“我们乐于看到中国于2022年正式加入《工业品外观设计国际注册海牙协定》，使得医疗器械能够更加便捷地获得外观设计保护；中欧两局专利合作条约国际检索单位试点项目也为西门子医疗等欧洲在华企业申请PCT国际专利提供了极大便捷。”西门子医疗大中华区副总裁浦峥嵘表示。

西井科技香港公司带来了参演《流浪地球2》的全时无人驾驶新能源商用车Q-Tractor，以及新能源无人驾驶牵引车Q-Truck。西井科技总裁章嵘介绍，为加快全球业务布局，西井科技充分利用商标注册马德里体系，高效地将品牌推广至全球市场。

近年来，中国不断深化知识产权国际交流合作，已与全球80多个国家和地区及国际组织建立了知识产权合作关系，专利审查高速路（PPH）合作网络持续拓展，连接上32个国家；同时，积极推动完善知识产权国际规则和标准，国际条约涉外工作机制持续建立健全，审查标准和审查结论获得更多域外认可。这些举措和成果都为创新要素“引进来”和“走出去”提供着关键助力。（李杨芳）